{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001641281","name":"Bolt Biotherapeutics, Inc.","summary":"Bolt Biotherapeutics is a clinical-stage biopharmaceutical company developing immune-stimulating antibody conjugates (ISACs) to harness the immune system against cancer. Its proprietary Boltbody ISAC platform combines tumor-targeting antibodies with immune-stimulating linker-payloads. Lead candidate BDC-4182 targets claudin 18.2 in gastric/gastroesophageal junction cancer and is in Phase 1 dose escalation. Other pipeline programs include a CEA ISAC, PD-L1 ISAC, and dectin-2 agonist antibody BDC-3042, currently on hold pending partnering or funding.","people":[],"products":[{"name":"BDC-4182","type":"platform","description":"Next-generation Boltbody ISAC targeting claudin 18.2 tumor-associated antigen, in Phase 1 dose escalation for gastric/gastroesophageal junction cancer."},{"name":"CEA ISAC","type":"platform","description":"Boltbody ISAC targeting carcinoembryonic antigen (CEA) expressed in colorectal, non-small cell lung, pancreatic, and breast cancers; preclinical stage."},{"name":"PD-L1 ISAC","type":"platform","description":"Anti-PD-L1 antibody conjugated to a TLR7/8 agonist payload targeting both tumor and immune cells expressing PD-L1; preclinical stage."},{"name":"BDC-3042","type":"platform","description":"First-in-class dectin-2 agonist antibody designed to repolarize tumor-associated macrophages; Phase 1 completed, development currently paused."},{"name":"Boltbody ISAC Platform","type":"platform","description":"Proprietary platform combining tumor-targeting antibodies with immune-stimulating linker-payloads; library of linker-payloads used in internal programs and collaborations."}],"partnerships":[],"affiliations":[],"origin":{"leaf":"44603507604bf23412bb3b149adab3ede3b314a3aa31138d6d72442f382300a8","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"a4b7ca90403e45b3b73b090ebe73c4d47a1f5beab1aa410e254a7308276b6ab9","parent":"662750cd022b670b24ee6322a53ec3f595e89f5716d86bb20aa17129bf79e035","source":"0001193125-26-104121","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":97,"hourly_limit":500,"remaining":403,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}